Published in Clin Infect Dis on October 16, 2012
Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act. Am J Public Health (2015) 0.94
Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests. BMC Infect Dis (2014) 0.82
Recent advances in understanding and managing Chlamydia trachomatis infections. F1000Prime Rep (2014) 0.81
An observational study to evaluate three pilot programmes of retesting chlamydia-positive individuals within 6 months in the South West of England. BMJ Open (2015) 0.75
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial. BMC Public Health (2016) 0.75
Assessing Spatial Relationships between Race, Inequality, Crime, and Gonorrhea and Chlamydia in the United States. J Urban Health (2017) 0.75
Retesting and repeat positivity following diagnosis of Chlamydia trachomatis and Neisseria gonorrhoea in New Zealand: a retrospective cohort study. BMC Infect Dis (2017) 0.75
The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health (2004) 3.95
Heterosexual anal sex activity in the year after an STD clinic visit. Sex Transm Dis (2008) 2.59
Trends in the diagnosis and treatment of ectopic pregnancy in the United States. Obstet Gynecol (2010) 2.50
The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis (2013) 2.39
Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol (2009) 1.87
Utilization of health services in physician offices and outpatient clinics by adolescents and young women in the United States: implications for improving access to reproductive health services. J Adolesc Health (2009) 1.76
Use of cervical cancer screening among insured women: the extent of missed opportunities. Health Policy (2004) 1.51
STD screening of HIV-infected MSM in HIV clinics. Sex Transm Dis (2010) 1.23
Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2012) 1.19
Missed opportunities for chlamydia screening of young women in the United States. Obstet Gynecol (2008) 1.12
Monitoring HIV testing at visits to emergency departments in the United States: very-low rate of HIV testing. J Acquir Immune Defic Syndr (2013) 1.09
Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis (2012) 1.05
Uptake of regular chlamydia testing by U.S. women: a longitudinal study. Am J Prev Med (2010) 1.04
Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics. Obstet Gynecol (2008) 1.01
H-NS binding and repression of the ctx promoter in Vibrio cholerae. J Bacteriol (2010) 1.01
A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies. Sex Transm Dis (2011) 1.01
Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China. Sex Transm Dis (2014) 0.99
Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Sex Transm Dis (2012) 0.99
Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005. Sex Transm Dis (2009) 0.99
Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis. J Clin Microbiol (2012) 0.97
Predictive value of clinical diagnostic codes for the CDC case definition of pelvic inflammatory disease (PID): implications for surveillance. Sex Transm Dis (2003) 0.97
Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis (2010) 0.92
Chlamydia screening in a Health Plan before and after a national performance measure introduction. Obstet Gynecol (2005) 0.91
Insights into the timing of repeated testing after treatment for Chlamydia trachomatis: data and modelling study. Sex Transm Infect (2012) 0.87
Differences in access to health care services among adults in rural America by rural classification categories and age. Aust J Rural Health (2003) 0.87
Provision of sexual health services to adolescent enrollees in Medicaid managed care. Am J Public Health (2002) 0.85
Epidemiologic research using administrative databases: garbage in, garbage out. Obstet Gynecol (2011) 0.82
Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol (2014) 0.82
Screening for human immunodeficiency virus and other sexually transmitted diseases among U.S. women with prenatal care. Obstet Gynecol (2015) 0.80
Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005. Sex Transm Dis (2009) 0.80
Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women. J Clin Microbiol (2013) 0.79
Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010. MMWR Surveill Summ (2014) 0.79
Demographic and Health Services Characteristics Associated With Testing for Sexually Transmitted Infections Among a Commercially Insured Population of HIV-Positive Patients. J Acquir Immune Defic Syndr (2015) 0.78
Higher yet suboptimal chlamydia testing rates at community health centers and outpatient clinics compared with physician offices. Am J Public Health (2012) 0.78
Prenatal syphilis screening rates measured using medicaid claims and electronic medical records. Sex Transm Dis (2008) 0.78
Successful treatment of Pasteurella multocida meningitis with aztreonam. Scand J Infect Dis (2007) 0.78
Racial and ethnic disparities in prenatal syphilis screening among women with Medicaid-covered deliveries in Florida. Matern Child Health J (2007) 0.78
Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007. Sex Transm Dis (2011) 0.77
Increase in Urgent Care Center Visits for Sexually Transmitted Infections, United States, 2010-2014. Emerg Infect Dis (2017) 0.75
Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013. Sex Transm Dis (2016) 0.75
Successful treatment of Pasteurella multocida meningitis with aztreonam. Scand J Infect Dis (2006) 0.75
Explaining racial differences in prenatal care initiation and syphilis screening among Medicaid-covered pregnant women. J Health Care Poor Underserved (2009) 0.75
Age-specific chlamydial infection among pregnant women in the United States: evidence for updated recommendations. Sex Transm Dis (2014) 0.75
Patterns in prenatal syphilis screening among Florida Medicaid enrollees. Sex Transm Dis (2007) 0.75
Sexually transmitted disease care in managed care organizations. Infect Dis Clin North Am (2005) 0.75
The Significant Impact of Different Insurance Enrollment Criteria on the HEDIS Chlamydia Screening Measure for Young Women Enrolled in Medicaid and Commercial Insurance Plans. Sex Transm Dis (2015) 0.75
Patterns of single and multiple claims of epididymitis among young privately-insured males in the United States, 2001 to 2004. Sex Transm Dis (2009) 0.75
Provider Adherence to Syphilis Testing Recommendations for Women Delivering a Stillbirth. Sex Transm Dis (2017) 0.75
Evaluating the quality of sexual health care provided to adolescents in medicaid managed care: a comparison of two data sources. Am J Med Qual (2004) 0.75
Suboptimal Prenatal Syphilis Testing Among Commercially Insured Women in the United States, 2013. Sex Transm Dis (2017) 0.75